Board of Directors
Shameze Rampertab, CPA, CAExecutive Member
Based in Canada, Shameze Rampertab is Zomedica’s Chief Financial Officer and corporate secretary. He leads the company’s finance operations to maximize profitability, shareholder value and brand excellence.
With 20 years of experience in the life science sector, Shameze has served as chief financial officer for multiple publicly traded healthcare startups, worked as an investment banker, and thrived as a sell-side health-equity research analyst. Before joining Zomedica, Shameze served as CFO and secretary at Profound Medical Corp., a TSX-V listed medical device company, and as CFO and Vice President of Finance for Intellipharmaceutics International Inc., a NADSAQ and TSX listed pharmaceutical company.
He received his chartered professional accountant (CPA) and chartered accountant (CA) designations from the Canadian Institute of Chartered Accountants after earning his MBA from McMaster University and Bachelor of Science in molecular genetics and molecular biology from the University of Toronto.
With over 30 years of experience in the specialty pharmacy industry, Jeff Rowe most recently served as Executive Vice President and board member of Diplomat Inc., the largest independent specialty pharmacy company in the United States. During his tenure with Diplomat, the company grew from a single location with less than US$5 million in revenue, to 16 locations and US$3 billion in sales, and became publicly traded on the New York Stock Exchange. Prior to that, Jeff owned two successful community pharmacies in Genesee County, Michigan.
An authority in pharmaceutical operations, Jeff offers critical insights into fundamental business strategies involving accreditation, contracting, cybersecurity and regulation, combined with an expertise in compounding and integrative medicine. He is uniquely qualified to identify process improvements and efficiencies while maintaining compliance and quality standards, for increased revenue, profitability and customer satisfaction. Jeff holds a Bachelor of Pharmacy degree from Ferris State University and has completed many health-related credential courses.
Rodney J. WilliamsIndependent Member
With over 20 years of medical technology and related healthcare experience, Rodney (Rod) Williams has demonstrated incredible agility and success in leading both large and small cap companies through growth cycles, while strengthening their product portfolio and boosting commercial planning competencies. He is currently the Global Vice President of Portfolio and Services with Align Technology, Inc., which designs and manufactures products for dental professionals, including the Invisalign® system. Prior to Align Technology, he was an entrepreneur-in-residence with the private equity investment firm PTV Healthcare Capital and before that was president and CEO of Heart Rhythm Society Consulting Services. He also served in senior executive positions with St. Jude Medical, GE Healthcare, Johnson and Johnson, and Bausch & Lomb.
Rod earned both his MBA and Bachelor of Science degrees from the University of Southern California (USC) and attended the General Management Executive Leadership Program at The Wharton School of Business. While at USC, on football scholarship, he gained NCAA Academic All-American honors and numerous academic awards as the TOP student-athlete. Rod was drafted into the National Football League in 1985.
Johnny D. PowersExecutive Member
Dr. Powers has more than 30 years of experience leading business strategy, operations, sales and marketing, and product development in the human and pet medical diagnostics markets. Notably, he held executive roles at animal health industry leader IDEXX Laboratories, Inc. (IDEXX), where, prior to his retirement, he served as executive vice president responsible for business performance, product innovation and commercial effectiveness across multiple point-of-care and reference laboratory businesses. Currently, Powers is the president and founder of JD Powers Consulting Group, which provides strategic and executive advisory services in the healthcare industry. Dr. Powers holds a bachelor's degree in chemistry from Wake Forest University, an M.S. in chemical engineering from Clemson University, an M.B.A. from the Duke University Fuqua School of Business and a Ph.D. in biochemical engineering from North Carolina State University.
Dr. Johnny D. Powers will provide day-to-day strategic oversight and management guidance to the Zomedica team. Dr. Powers has extensive animal healthcare industry experience, most recently with IDEXX Laboratories where he was Executive Vice President with responsibility for product pipeline and commercialization across multiple business units. Over his career, Dr. Powers has overseen the development and commercialization of hundreds of diagnostic platforms and assays across the pet and human healthcare industries. In his new role, he will work closely with the executive leadership team with a primary focus on driving our new products into commercialization.